Keynotes sessions or lectures
- Immunotherapy in cancer, how does it work? How does it not work? New challenges – Joao Goncalves, Portugal
- mRNA vaccines in cancer – the next future – Niels Halama, Germany
- Why and how should we screen for Prostate cancer? Recommendations from the EU Council – Hein Van Poppel, Belgium
- Breast cancer update – N.N.
Clinical and Practical Sessions
- Antibody drug conjugate development, where are we?
Clinical issues, stability, and occupational safety issues - Pharmacogenomics 2023 and clinical oncology pharmacists: what do we need to know?
- Cellular and gene therapy medicine management systems
- In house production of CAR-T therapy
- Drug safety and clean working
Results of the intralaboratory study - Pragmatic trials and evolution of clinical trials methodologies in oncology
- Psycho Oncology: what clinical oncology pharmacists need to know?
- Prostate cancer: guidelines 2023
- Innovative drugs in hematology: highlights of 2023
- Joint session ESOP – SIOP European Society for Pediatric Oncology
Workshops and interactive sessions
- Management of drug-drug interactions
- Pharmaceutical consultations, which evolutions?
- Immunotherapy: an opportunity for clinical pharmacists
Prevention and management of side effects, interactions with gut microbiota interactions… - How to implement Therapeutic Drug Monitoring in Oncology
- How to work multiprofessionally in cases
- Supportive care and involvement of clinical oncology pharmacists
- Herbal medicines and cancer patients’ behaviour: pharmacological and psychological issues
- Role of clinical oncology pharmacists in tumor boards
- Progress in medical devices in oncology
- Joint session ESOP – EONS European Oncology Nursing Society: clinical cases
Debate and Round table discussions
- New challenges surrounding biosimilars: shortages in biosimilars, iv versus sc discussion…
- “Derogatory access to new oncology drugs”: regulatory and ethical issues: reaching equal access for all patients? High-cost oncology drugs and proof of added benefit.
- 2023 EU pharmaceutical package
- What about adherence of oral anticancer drugs (Session with patient advocate speakers)
- Burnout and wellbeing in oncology pharmacists
Other topics
- Activities of the “Young professionals’ group in ECO
- Oral communications session: selected best abstracts
- Corner presentations
- Industry sponsored symposiums
- ESOP news of the world
- ESOP research projects and actually updates: QuapoS, EUSOP, outcomes of the SIGs, ESOP certification issues
The program will be updated regularly.